Skip to main content
Clinical Trials/ISRCTN65477168
ISRCTN65477168
Completed
Not Applicable

A randomised controlled study of combination therapy in rheumatoid arthritis (RA) patients with a suboptimal response to sulphasalazine

Arthritis Research Campaign (ARC) (UK)0 sites0 target enrollmentJuly 10, 2002

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Rheumatoid arthritis
Sponsor
Arthritis Research Campaign (ARC) (UK)
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 10, 2002
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional

Investigators

Sponsor
Arthritis Research Campaign (ARC) (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Male or female
  • 2\. Age 18 \- 75 years
  • 3\. Onset of disease after age 16
  • 4\. Disease duration less than 5 years
  • 5\. Active inflammatory arthritis which is defined as six or more swollen joints plus two of the following:
  • 5\.1\. Morning stiffness more than 45 minutes
  • 5\.2\. Nine or more tender joints
  • 5\.3\. Erythrocyte Sedimentation Rate (ESR) more than 28 mm/h

Exclusion Criteria

  • Not provided at time of registration

Outcomes

Primary Outcomes

Not specified

Similar Trials